Abstract: Topical gel and cream formulations containing human plasma fibronectin and other wound healing promoters are used for the healing of cutaneous wounds. The formulations provide slow release and increased contact time of fibronectin and of other wound healing promoters to the wound site leading to the effective absorption of the promoters.